Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective

Review Group ◽

Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”

PharmacoEconomics ◽

10.1007/s40273-017-0507-3 ◽

2017 ◽

Vol 35 (6) ◽

pp. 665-667

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Florian Tomini ◽

Thea van Asselt ◽

Sohan Deshpande ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Letter To The Editor ◽

Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0481-1 ◽

2016 ◽

Vol 35 (7) ◽

pp. 717-726 ◽

Cited By ~ 2

Author(s):

Lesley Uttley ◽

Sophie Whyte ◽

Timothy Gomersall ◽

Shijie Ren ◽

Ruth Wong ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0457-1 ◽

2016 ◽

Vol 35 (4) ◽

pp. 415-424 ◽

Cited By ~ 3

Author(s):

Benjamin Kearns ◽

Abdullah Pandor ◽

Matt Stevenson ◽

Jean Hamilton ◽

Duncan Chambers ◽

...

Keyword(s):

Prostate Cancer ◽

Metastatic Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”

PharmacoEconomics ◽

10.1007/s40273-017-0502-8 ◽

2017 ◽

Vol 35 (6) ◽

pp. 661-663 ◽

Cited By ~ 1

Author(s):

Odette Reifsnider ◽

Fiona Hall ◽

Sonja Sorensen ◽

Irina Proskorovsky ◽

Isabelle Girod ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0445-5 ◽

2016 ◽

Vol 35 (2) ◽

pp. 191-202 ◽

Cited By ~ 7

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Florian Tomini ◽

Thea van Asselt ◽

Sohan Deshpande ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0436-6 ◽

2016 ◽

Vol 34 (12) ◽

pp. 1241-1253 ◽

Cited By ~ 5

Author(s):

Rachid Rafia ◽

Alison Scope ◽

Sue Harnan ◽

John W. Stevens ◽

Matt Stevenson ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Prior Therapy ◽

Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0725-3 ◽

2018 ◽

Vol 37 (6) ◽

pp. 753-762

Author(s):

Joanna Picot ◽

Neelam Kalita ◽

Wendy Gaisford ◽

Petra Harris ◽

Oluchukwu Onyimadu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Hormone Receptor Positive ◽

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0738-y ◽

2018 ◽

Vol 37 (7) ◽

pp. 887-894 ◽

Cited By ~ 2

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Sabine Grimm ◽

Debra Fayter ◽

Sohan Deshpande ◽

...

Keyword(s):

Arsenic Trioxide ◽

Acute Promyelocytic Leukaemia ◽

Evidence Review Group ◽

Promyelocytic Leukaemia ◽

Technology Appraisal ◽

Review Group ◽

Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0743-1 ◽

2018 ◽

Vol 37 (5) ◽

pp. 739-739

Author(s):

Lindsay Claxton ◽

Joanne O’Connor ◽

Nerys Woolacott ◽

Kath Wright ◽

Robert Hodgson

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Evidence Review Group ◽

Small Cell ◽

Technology Appraisal ◽

Small Cell Lung ◽

Review Group ◽

Anaplastic Lymphoma ◽

Group Evaluation ◽

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-021-01098-3 ◽

2021 ◽

Author(s):

Sabine E. Grimm ◽

Willem Witlox ◽

Robert Wolff ◽

Annette Chalker ◽

Mickael Hiligsmann ◽

...

Keyword(s):

Mycosis Fungoides ◽

Evidence Review Group ◽

Sézary Syndrome ◽

Sezary Syndrome ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽